We use Google Analytics to see which pages are read and how the site is used, so we know what to improve. This only runs if you accept. See our privacy notice for details.

Dáil

Written answer

Healthcare Policy

209. Deputy Tom Brabazon asked the Minister for Health the steps that are being taken, in conjunction with the HSE, to address delays in clinical assessments for adults with SMA seeking access to Risdiplam; the resources being made available to ensure sufficient appropriately qualified healthcare professionals are in place to undertake the required assessments and support the treatment pathway; and the timeline in place to ensure that eligible adults can access Risdiplam without avoidable delay. [79858/26]

Comment on this

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comment on this